Connor, Clark & Lunn Investment Management (CC&L)
KNTE

Connor, Clark & Lunn Investment Management (CC&L)’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio KNTE Stock Details KNTE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-76,836
Closed -$182K – 1748
2023
Q4 		$182K Buy
76,836
+24,668
+47% +$58.5K ﹤0.01% 1276
2023
Q3 		$73K Buy
+52,168
New +$73K ﹤0.01% 1312